Home / CANCER BUZZ Podcast

CANCER BUZZ Podcast

Want the latest BUZZ? Just listen in!

The CANCER BUZZ podcast features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.

Listen to the CANCER BUZZ podcast on Apple Podcasts, Spotify, Amazon Music, or wherever you get your podcasts. You can now listen with your smart home device. For instructions on how to listen with Alexa, click here, or just tell Alexa to "Play CANCER BUZZ." For Google Home instructions, click here.

Filter By Topic

Clear filter

Filter By Podcast Format

 
 
 
 
 
Hear from a pharmacist and an oncology operations manager as they share how the digital Patient Assistance Guide tool can help you find resources in less time so patients can access—and better afford—their cancer treatments.
Hear from two authors of an ACCC/LUNGevity Foundation study that identified key areas of clinician need related to biomarker testing in NSCLC.
In this episode, we'll hear the evolution of the advanced practitioners (APs) role at her institution, where APs have a larger voice in the research process and clinical trial protocols, serve as champions to advocate for patients and research staff, and collaborate with their team to promote best practices in clinical trial delivery.
A physician and administrator champion at Cone Health Cancer Center share why it’s more important than ever to make transportation assistance services available to patients with cancer.
In this episode, we'll explore how oncology advanced practitioners (APs) can play a greater role in clinical research and, according to a recent national study, have a strong interest in doing so.
In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials.
Learn about the cultural and logistical barriers to end-of-life health equity and discover strategies that programs can implement to both address palliative care earlier in the care continuum and reduce health disparities.
We discuss how the legacy of racism in American healthcare continues to affect today’s research, and share strategies for cancer programs to effectively communicate with underrepresented and marginalized populations.
Discover what steps cancer programs can take to build trust with patients from marginalized and underrepresented groups and ensure a more equitable and accessible healthcare environment.
Explore the barriers and challenges that LGBTQ+ patients with cancer face, and how cancer programs can make their care more inclusive.
Learn about the importance of reaching diverse populations with clinical trials where they live and how one clinical trial has prioritized community engagement.
Learn how the Livestrong Cancer Institutes and Dell Medical School at the University of Texas at Austin are reaching out to young women in high school to generate interest in oncology.
Laura Holmes Haddad shares how her battle with breast cancer changed her perception of the resources available to younger adults with cancer, and what cancer programs can do to meet their needs.
We look at how rural cancer care teams are managing to provide quality care with limited resources during the COVID-19 pandemic.
We talk to a medical oncologist in a rural Montana community about the realities of rural cancer care, the importance of community oncology, and how he navigates common barriers to quality care.
Learn how a rural health system harnessed its passion and creativity to work around obstacles to clinical trial access and ensure its patients have access to cutting-edge cancer treatments.
Learn more about the challenges to cancer care delivery in rural settings, and discover some of the innovative ways that they are working to better serve this at-risk patient population.
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.